Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

AI reads x-rays to determine cardiac device manufacturer

An AI platform designed to quickly read an x-ray and determine the manufacturer and model of a cardiac rhythm device may quicken treatment in the event of device failure.

PET/MRI may uncover atherosclerosis at early stage

Hybrid PET/MRI revealed inflammation in plaque-free arterial segments in a sizable proportion of patients with subclinical atherosclerosis, suggesting the imaging technique may provide a lens into early stages of cardiovascular disease.

Ebit (Esaote Group) and DiA Imaging Analysis have partnered offering Advanced AI-based Cardiac Ultrasound Analysis

BE'ER SHEVA, Israel — Genoa, Italy — DiA Imaging Analysis, a leading provider of artificial intelligence (AI)-powered ultrasound analysis tools, announced today that it has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo Cardiac Toolbox as an integrated part of Ebit's SUITESTENSA CVIS (Cardiovascular Information System) PACS.

Thumbnail

Intravascular ultrasound may provide better long-term outcomes in complex PCI

Intravascular ultrasound (IVUS)-guided PCI was associated with lower long-term risk of cardiac death than an angiography-guided approach in patients with complex lesions, according to a single-center study published in JACC: Cardiovascular Interventions.

Thumbnail

Radiologists often overlook cardiovascular warning signs during cancer imaging

Radiologists commonly overlook potentially important information about a patient’s heart health when they’re performing mammograms or CT scans before starting cancer treatment, according to research set to be presented at the American College of Cardiology’s scientific sessions March 16-18 in New Orleans.

Ultrasound societies want the FDA to remove contrast label warning

The International Contrast Ultrasound Society (ICUS) is again urging the FDA to remove the “black box” warning from ultrasound contrast agent (UCA) labels, following its filing of a September 2018 citizen petition with the federal agency.

Thumbnail

CT angiography trumps functional testing in diabetic patients with suspected CAD

A new analysis from the PROMISE trial suggests CT angiography (CTA) may be a superior front-line diagnostic test for patients with diabetes and symptoms suggestive of coronary artery disease (CAD).

Aidoc announces CE mark for the first AI-based workflow tool for Pulmonary Embolism

Aidoc’s solution for flagging and prioritizing pulmonary embolisms is now commercially available in Europe